Sudarshan Pharma [SUDARSHAN] vs Chemplast Sanmar [CHEMPLASTS] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Sudarshan Pharma Industries Ltd. wins in 9 metrics, Chemplast Sanmar Ltd. wins in 8 metrics, with 0 ties. Sudarshan Pharma Industries Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sudarshan Pharma Industries Ltd. | Chemplast Sanmar Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 35.73 | 210.40 | Sudarshan Pharma Industries Ltd. |
| Price-to-Book Ratio | 5.61 | 2.02 | Chemplast Sanmar Ltd. |
| Debt-to-Equity Ratio | 155.50 | 96.73 | Chemplast Sanmar Ltd. |
| PEG Ratio | N/A | 1.47 | N/A |
| EV/EBITDA | 20.44 | 62.22 | Sudarshan Pharma Industries Ltd. |
| Profit Margin (TTM) | 3.26% | -7.01% | Sudarshan Pharma Industries Ltd. |
| Operating Margin (TTM) | 5.93% | -13.16% | Sudarshan Pharma Industries Ltd. |
| EBITDA Margin (TTM) | 5.93% | N/A | N/A |
| Return on Equity | 12.13% | -5.34% | Sudarshan Pharma Industries Ltd. |
| Return on Assets (TTM) | 3.96% | -1.70% | Sudarshan Pharma Industries Ltd. |
| Free Cash Flow (TTM) | $304.76M | $-2.11B | Sudarshan Pharma Industries Ltd. |
| 1-Year Return | 19.22% | -49.01% | Sudarshan Pharma Industries Ltd. |
| Price-to-Sales Ratio (TTM) | 1.12 | 0.95 | Chemplast Sanmar Ltd. |
| Enterprise Value | $9.53B | $52.84B | Chemplast Sanmar Ltd. |
| EV/Revenue Ratio | 1.48 | 1.28 | Chemplast Sanmar Ltd. |
| Gross Profit Margin (TTM) | 12.03% | 31.44% | Chemplast Sanmar Ltd. |
| Revenue per Share (TTM) | $26 | $260 | Chemplast Sanmar Ltd. |
| Earnings per Share (Diluted) | $0.84 | $-18.05 | Sudarshan Pharma Industries Ltd. |
| Beta (Stock Volatility) | 0.69 | 0.01 | Chemplast Sanmar Ltd. |
Sudarshan Pharma Industries Ltd. vs Chemplast Sanmar Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sudarshan Pharma Industries Ltd. | 0.29% | -6.63% | 10.91% | 32.55% | 30.44% | 27.16% |
| Chemplast Sanmar Ltd. | -0.67% | -6.65% | -9.47% | -7.17% | -26.07% | -18.98% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sudarshan Pharma Industries Ltd. | 19.22% | 423.13% | 459.90% | 459.90% | 459.90% | 459.90% |
| Chemplast Sanmar Ltd. | -49.01% | -51.86% | -60.15% | -60.15% | -60.15% | -60.15% |
Performance & Financial Health Analysis: Sudarshan Pharma Industries Ltd. vs Chemplast Sanmar Ltd.
| Metric | SUDARSHAN | CHEMPLASTS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹7.29B | ₹38.60B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 307,600 | 363,895 |
| 90 Day Avg. Volume | 248,667 | 432,557 |
| Last Close | ₹34.47 | ₹206.06 |
| 52 Week Range | ₹18.50 - ₹36.95 | ₹203.60 - ₹477.75 |
| % from 52W High | -6.71% | -56.87% |
| All-Time High | ₹452.70 (Sep 30, 2024) | ₹826.00 (Oct 11, 2021) |
| % from All-Time High | -92.39% | -75.05% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.45% | -0.21% |
| Quarterly Earnings Growth | 0.51% | -0.21% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | -0.07% |
| Operating Margin (TTM) | 0.06% | -0.13% |
| Return on Equity (TTM) | 0.12% | -0.05% |
| Debt to Equity (MRQ) | 155.50 | 96.73 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹5.35 | ₹122.81 |
| Cash per Share (MRQ) | ₹0.11 | ₹35.59 |
| Operating Cash Flow (TTM) | ₹8.46M | ₹-16,100,000 |
| Levered Free Cash Flow (TTM) | ₹159.55M | ₹-1,103,600,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Sudarshan Pharma Industries Ltd. vs Chemplast Sanmar Ltd.
| Metric | SUDARSHAN (Apr 24, 2026) | CHEMPLASTS (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 35.73 | 210.40 |
| Forward P/E | N/A | 35.91 |
| PEG Ratio | N/A | 1.47 |
| Price to Sales (TTM) | 1.12 | 0.95 |
| Price to Book (MRQ) | 5.61 | 2.02 |
| Market Capitalization | ||
| Market Capitalization | ₹7.29B | ₹38.60B |
| Enterprise Value | ₹9.53B | ₹52.84B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.48 | 1.28 |
| Enterprise to EBITDA | 20.44 | 62.22 |
| Risk & Other Metrics | ||
| Beta | 0.69 | 0.01 |
| Book Value per Share (MRQ) | ₹5.35 | ₹122.81 |
Financial Statements Comparison: Sudarshan Pharma Industries Ltd. vs Chemplast Sanmar Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | SUDARSHAN (2025) | CHEMPLASTS (2025) |
|---|---|---|
| Revenue/Sales | 5.05B | 43.28B |
| Cost of Goods Sold | 4.40B | 28.56B |
| COGS % of Revenue | 87.1% | 66.0% |
| Gross Profit | 651.01M | 14.72B |
| Gross Margin | 12.9% | 34.0% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 379.01M | 530.00M |
| Operating Margin | 7.5% | 1.2% |
| EBITDA | 407.72M | 1.55B |
| EBITDA Margin | 8.1% | 3.6% |
| Pre-Tax Income | 216.29M | -1.69B |
| Pre-Tax Income % of Revenue | 4.3% | -3.9% |
| Income Tax | 56.77M | -587.10M |
| Income Tax % of Revenue | 1.1% | -1.4% |
| Net Income (Profit) | 159.53M | -1.10B |
| Profit Margin | 3.2% | -2.5% |
Balance Sheet & Liquidity Metrics
| Metric | SUDARSHAN (2025) | CHEMPLASTS (2025) |
|---|---|---|
| Cash & Equivalents | 5.51M | 5.55B |
| Total Current Assets | 3.35B | 17.75B |
| Total Current Assets % of Revenue | 66.3% | 41.0% |
| Total Current Liabilities | 2.60B | 27.15B |
| Total Current Liabilities % of Revenue | 51.4% | 62.7% |
| Long-Term Debt | 104.60M | 11.02B |
| Long-Term Debt % of Revenue | 2.1% | 25.5% |
| Total Shareholders Equity | 1.31B | 20.68B |
| Retained Earnings | N/A | 16.89B |
| Retained Earnings % of Revenue | 0.0% | 39.0% |
| Property, Plant & Equipment | 200.50M | 44.93B |
Cash Flow Statement Comparison
| Metric | SUDARSHAN (2025) | CHEMPLASTS (2025) |
|---|---|---|
| Operating Cash Flow | 8.46M | -16.10M |
| Operating Cash Flow % of Revenue | 0.2% | 0.0% |
| Capital Expenditures | -47.46M | -3.60B |
| Free Cash Flow | 304.76M | -2.11B |
| FCF Margin | 6.0% | -4.9% |
| Debt Repayment | N/A | -15.34B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SUDARSHAN | CHEMPLASTS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 240.66M | 158.11M |
| Float Shares | 87.72M | 61.38M |
| % Held by Insiders | 76.52% | 54.99% |
| % Held by Institutions | 0.00% | 36.24% |
| % Held by Public | 23.48% | 8.77% |
Dividend Analysis & Yield Comparison: Sudarshan Pharma Industries Ltd. vs Chemplast Sanmar Ltd.
| Metric | SUDARSHAN | CHEMPLASTS |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |